Impact of social determinants on antiretroviral therapy access and outcomes entering the era of universal treatment for people living with HIV in Italy

[1]  G. Woelk,et al.  Optimizing linkage to care and initiation and retention on treatment of adolescents with newly diagnosed HIV infection , 2017, AIDS.

[2]  R. Granich,et al.  Status and methodology of publicly available national HIV care continua and 90-90-90 targets: A systematic review , 2017, PLoS medicine.

[3]  S. Geerlings,et al.  The importance of registration of sexual orientation and recognition of indicator conditions for an adequate HIV risk-assessment , 2017, BMC Infectious Diseases.

[4]  O. Kirk,et al.  Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe , 2017 .

[5]  J. delAmo.  Inequalities by educational level in response to combination antiretroviral treatment and survival in HIV-positive men and women in Europe , 2016, AIDS.

[6]  S. Abgrall,et al.  Effect of sociodemographic factors on survival of people living with HIV , 2016, Current opinion in HIV and AIDS.

[7]  F. Lert,et al.  Determinants of Virological Response to Antiretroviral Therapy: Socio-Economic Status Still Plays a Role in the Era of cART. Results from the ANRS-VESPA 2 Study, France , 2016, Antiviral therapy.

[8]  Richard D Moore,et al.  A longitudinal, HIV care continuum: 10-year restricted mean time in each care continuum stage after enrollment in care, by history of IDU , 2016, AIDS.

[9]  J. Skarbinski,et al.  Understanding Cross-Sectional Racial, Ethnic, and Gender Disparities in Antiretroviral Use and Viral Suppression Among HIV Patients in the United States , 2016, Medicine.

[10]  A. d’Arminio Monforte,et al.  Increased risk of virologic failure to the first antiretroviral regimen in HIV-infected migrants compared to natives: data from the ICONA cohort. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[11]  M. Carrieri,et al.  Twelve-Year Mortality in HIV-Infected Patients Receiving Antiretroviral Therapy: The Role of Social Vulnerability. The ANRS CO8 APROCO-COPILOTE cohort , 2015, Antiviral therapy.

[12]  L. Myer,et al.  Age in antiretroviral therapy programmes in South Africa: a retrospective, multicentre, observational cohort study. , 2015, The lancet. HIV.

[13]  M. Ory,et al.  Sexual Behaviors, Healthcare Interactions, and HIV-Related Perceptions Among Adults Age 60 Years and Older: An Investigation by Race/Ethnicity. , 2015, Current HIV research.

[14]  J. Kaldor,et al.  Recording the sexual orientation of male patients attending general practice. , 2015, Family Practice.

[15]  M. Egger,et al.  Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland , 2015, AIDS.

[16]  J. Sterne,et al.  Sex Differences in Overall and Cause-Specific Mortality among HIV-Infected Adults on Antiretroviral Therapy in Europe, Canada and the US , 2015, Antiviral therapy.

[17]  O. Kirk,et al.  Delayed HIV diagnosis and initiation of antiretroviral therapy: inequalities by educational level, COHERE in EuroCoord , 2014, AIDS.

[18]  K. Arheart,et al.  Tobacco Smoking Increases Immune Activation and Impairs T-Cell Function in HIV Infected Patients on Antiretrovirals: A Cross-Sectional Pilot Study , 2014, PloS one.

[19]  C. Larsen,et al.  Educational attainment and risk of HIV infection, response to antiretroviral treatment, and mortality in HIV-infected patients , 2014, AIDS.

[20]  A. d’Arminio Monforte,et al.  Caring for women living with HIV: gaps in the evidence , 2013, Journal of the International AIDS Society.

[21]  M. Marmot,et al.  WHO European review of social determinants of health and the health divide , 2012, The Lancet.

[22]  Guoxing Soon,et al.  Meta-analysis of gender differences in efficacy outcomes for HIV-positive subjects in randomized controlled clinical trials of antiretroviral therapy (2000-2008). , 2012, AIDS patient care and STDs.

[23]  J. Blanco,et al.  Educational Gradient in HIV Diagnosis Delay, Mortality, Antiretroviral Treatment Initiation and Response in a Country with Universal Health Care , 2012, Antiviral therapy.

[24]  Richard D Moore,et al.  CD4 count at presentation for HIV care in the United States and Canada: Are those over 50 years more likely to have a delayed presentation? , 2010, AIDS research and therapy.

[25]  G. Ippolito,et al.  Delayed Presentation and Late Testing for HIV: Demographic and Behavioral Risk Factors in a Multicenter Study in Italy , 2004, Journal of acquired immune deficiency syndromes.

[26]  R. Greenblatt,et al.  Erratum: Does patient sex affect human immunodeficiency virus levels? (Clinical Infectious Diseases (2002) 35 (313-322)) , 2002 .

[27]  R. Greenblatt,et al.  Does patient sex affect human immunodeficiency virus levels? , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.